GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

GETI.B

188.75

+0.4%↑

EKTA.B

57.7

+2.3%↑

ATT

101.8

+0.99%↑

AMBEA

133.5

+0.07%↑

ARJOB

25.38

-1.17%↓

Home・Aandelen Lijst・Vivesto AB

Vivesto AB

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Inkomsten	-1.9M -9.1M
EPS	-0.015
Werknemers	4
EBITDA	-1.8M -8.9M

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-1.9M 49M
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Vivesto AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 mrt 2026, 21:37 UTC

Acquisities, Fusies, Overnames

Lensar and Alcon Agree to Terminate Merger

16 mrt 2026, 19:06 UTC

Belangrijke Nieuwsgebeurtenissen

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16 mrt 2026, 17:44 UTC

Acquisities, Fusies, Overnames

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16 mrt 2026, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 mrt 2026, 23:46 UTC

Marktinformatie

Nikkei May Rise After Oil Prices Decline -- Market Talk

16 mrt 2026, 23:37 UTC

Marktinformatie

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16 mrt 2026, 23:05 UTC

Marktinformatie

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16 mrt 2026, 21:56 UTC

Marktinformatie

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16 mrt 2026, 21:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

16 mrt 2026, 21:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mrt 2026, 20:57 UTC

Acquisities, Fusies, Overnames

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16 mrt 2026, 20:51 UTC

Acquisities, Fusies, Overnames

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16 mrt 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

16 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

16 mrt 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

16 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

16 mrt 2026, 19:53 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16 mrt 2026, 19:43 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 mrt 2026, 19:43 UTC

Marktinformatie

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16 mrt 2026, 19:37 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Natural Gas Follows Oil Prices Lower -- Market Talk

16 mrt 2026, 19:20 UTC

Belangrijke Nieuwsgebeurtenissen

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16 mrt 2026, 19:17 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16 mrt 2026, 19:00 UTC

Marktinformatie

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16 mrt 2026, 18:23 UTC

Marktinformatie

LME Restarts Trading After Outage -- Market Talk

16 mrt 2026, 17:36 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16 mrt 2026, 17:19 UTC

Marktinformatie

Grains Sink as Investors Steer Toward Equities -- Market Talk

16 mrt 2026, 17:14 UTC

Belangrijke Nieuwsgebeurtenissen

Trump Ends News Conference

Peer Vergelijking

Prijswijziging

Vivesto AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.